BioSig to Participate at The 14th Annual International Symposium on Ventricular Arrhythmias: Pathophysiology & Therapy

NEXT STORY
United Arab Emirates Molecular Diagnostic Analyzers and Reagent Forecasts for 100 Tests 2019: Supplier Shares and Strategies, Volume and Sales Segment Forecasts
PREV STORY
Bahrain Molecular Diagnostic Analyzers and Reagent Forecasts for 100 Tests, 2019: Infectious and Genetic Diseases, Cancer, Forensic and Paternity Testing
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Coherus BioSciences Completes two Pharmacokinetic Bioequivalence Studies of CHS-0214

REDWOOD CITY, Calif., Oct. 06, 2016 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (Nasdaq:CHRS) a ...

author_avatar
NASDAQ Market News

Five Prime Therapeutics Announces $25 Million Payment by Bristol-Myers Squibb for Cabiralizumab Development Milestone

SOUTH SAN FRANCISCO, Calif., Jan. 25, 2018 (GLOBE NEWSWIRE) -- Five Prime Therapeutics, Inc. (Nasdaq:FPRX), ...

author_avatar
NASDAQ Market News

Immunocore Announces Leadership Change

PRESS RELEASE Immunocore Announces Leadership Change Oxford, UK and Philadelphia, USA, 8 February 2018 ...

author_avatar
NASDAQ Market News